首页> 美国卫生研究院文献>Annals of The Royal College of Surgeons of England >The highs and lows of endovascular aneurysm repair: the first two years of the Eurostar Registry.
【2h】

The highs and lows of endovascular aneurysm repair: the first two years of the Eurostar Registry.

机译:血管内动脉瘤修复的高潮和低谷:欧洲之星注册中心的头两年。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Eurostar Registry was established in 1996 to collate information, from centres across Europe, on the outcome from endovascular grafting of aortic aneurysms. At the end of the first year of the project, data on 430 patients had been entered onto the database. In 420 patients (97.7%), the endografts were deployed without major complications. The 30-day mortality rate was low at 3.4% and deaths were confined mostly to 'high risk' patients with major co-morbidity. Endoleaks, which were present on discharge from hospital in 15.7% of patients, were associated with a significantly increased incidence of continued expansion of the aneurysm sac postoperatively (P < 0.01). Thus the early results confirmed the feasibility and low complication rate of endovascular repair of aneurysms, but a higher than expected incidence of endoleaks. At 2 years, 895 patients had been registered. The rate of early endoleaks remained significantly unchanged but another 18% of patients had developed new endoleaks during the first year of follow-up. Six delayed ruptures had been reported, 3 fatal. There were indications that 'self sealed' endoleaks continued to pressurise the aneurysm sac. Severe distortion of the grafts with kinking and other structural changes associated with postoperative longitudinal shrinking of the aneurysm sac was observed in 69% of patients at 1 year. Clinical complications associated with these changes included late endoleak and graft limb occlusion. Early unrealistic optimism about endovascular aneurysm repair has been replaced with a more realistic understanding of its benefits and limitations as a result of the Eurostar project and other registries. Randomised studies are now required to establish the most appropriate role for this approach, alongside established therapies.
机译:欧洲之星注册中心成立于1996年,旨在收集来自欧洲各个中心的有关主动脉瘤血管内移植结果的信息。在该项目的第一年末,已将430名患者的数据输入数据库。在420例患者(占97.7%)中,没有严重并发症地进行了内移植。 30天死亡率很低,仅为3.4%,并且死亡主要限于严重合并症的“高风险”患者。出院时存在内漏的患者占15.7%,与术后动脉瘤囊持续扩张的发生率显着增加有关(P <0.01)。因此,早期结果证实了动脉瘤的血管内修复的可行性和低并发症发生率,但高于预期的内漏发生率。在2年时,已经登记了895名患者。早期内漏的发生率没有明显变化,但是在随访的第一年中,又有18%的患者出现了新的内漏。据报道有6次延迟破裂,其中3人死亡。有迹象表明“自密封”内漏继续使动脉瘤囊加压。在1年时,有69%的患者观察到移植物严重扭曲,扭结和其他与术后动脉瘤囊纵向收缩相关的结构变化。与这些变化相关的临床并发症包括晚期内漏和移植物四肢闭塞。由于欧洲之星计划和其他注册机构的结果,人们对血管内动脉瘤修复的早期不切实际的乐观态度已被更实际的了解所取代,从而对其益处和局限性有了更实际的了解。现在需要进行随机研究以确立这种方法最合适的作用,同时建立既定的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号